On August 17, 2023, Wang Weiwei, executive director and general manager of Sinopsin Chuangfu Medical Technology (Shanghai) Co., LTD., Liu Lin, assistant general manager, and Luo Yi, general manager of Sichuan Sinopsin Chuangke Medical Technology Co., LTD., and other three people visited the institute for research and discussion and talked about cooperation matters. Zeng Bin, Secretary general of Chengdu High and New Technology Association, Ai He, deputy secretary general and four comrades from the Department of Business Development attended the symposium.

The symposium was held in an atmosphere of friendly cooperation. Through full exchanges, the two sides deepened understanding and jointly explored and talked about new opportunities for cooperation.

Sinopharm Holding Co., Ltd. ranked 24th on the Fortune China 500 List of listed companies in 2023. Sinopharm Chuangfu Medical Technology (Shanghai) Co., Ltd. is a subsidiary company of Sinopharm Corporation. Wang Weiwei Executive director said that the company has been committed to the company's business scope includes: In the fields of medical technology, biotechnology, information technology, medical equipment and computer technology, technology development, technology transfer, technical consulting, technical services, rental of own equipment and other resources, to create a high-end, standardized, intelligent and large-scale smart medical service platform, the current business coverage is wide, hoping to combine the channel advantages with the resource advantages of the society, focusing on the subdivision track. Deepen cooperation.

During the discussion, the two sides discussed ways of exchange and cooperation in various fields such as medicine, education, research and industry, hoping to take this opportunity to integrate resources of all parties and refine cooperation contents. Use 5G, AI, big data, blockchain, cloud computing and other technical means to provide medical equipment full life cycle operation and maintenance services. Relying on scientific top-level design and efficient underlying logic, establish a strong middle desk, empower the front desk and link the back office, precipitate big data assets, innovate, derive, iterate and evolve a new business model, create a 1+N value-added service system, and promote the high-quality development of medical engineering services with high-end, standardized, intelligent and networked.